Study Details
Testing the Drug Ubrogepant in Adults and Young Adults with Migraine
(IRB#: IRB_00149183)
Migraine is a reoccurring headache that varies in pain and can cause other health issues such as sick to the stomach, and sensitivity to light and sound. The study will test a drug called Ubrogepant to treat people with the disease. The study wants to see if the drug will help people with the disease and is safe. People in this study will be randomly treated with the Ubrogepant or a placebo. The drug and placebo are swallowed as a pill. This placebo does not have the treatment. Participation in the study is about 6-7 months. Medical tests will be done in-person, on the phone, and online such as using a computer during the study to track the health of participants.
- All genders
- Under 18 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Under 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- Ages 6 to 17 years old
- History of migraine
- Migraines last about 3-72 hours
- Use of current or past medication of at least 1 pill for migraine
- Participants use specific birth control
Exclusion Criteria
- History of other diseases such as heart and brain disease
- Self-harm or thoughts of suicide
- Alcohol or drug abuse
- Pregnant
Will I be paid for my time?
Yes
IRB#: IRB_00149183
PI: Meghan Candee
Department: PEDIATRIC NEUROLOGY
Approval Date: 2023-05-17 06:00:00
Study Categories: Brain Health Studies
Specialties: Neurology